These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6134816)

  • 21. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
    Lin JH; Chiba M; Balani SK; Chen IW; Kwei GY; Vastag KJ; Nishime JA
    Drug Metab Dispos; 1996 Oct; 24(10):1111-20. PubMed ID: 8894513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition and induction of drug biotransformation in vivo by 8-methoxypsoralen: studies of caffeine, phenytoin and hexobarbital metabolism in the rat.
    Mays DC; Nawoot S; Hilliard JB; Pacula CM; Gerber N
    J Pharmacol Exp Ther; 1987 Oct; 243(1):227-33. PubMed ID: 3668854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peculiar pharmacokinetics of brallobarbital as a source of complications in Vesparax intoxication.
    Yih TD; Rossum JM
    Xenobiotica; 1976 Jun; 6(6):355-62. PubMed ID: 969563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenobarbital in the genetically obese Zucker rat. I. Pharmacokinetics after acute and chronic administration.
    Brouwer KL; Kostenbauder HB; McNamara PJ; Blouin RA
    J Pharmacol Exp Ther; 1984 Dec; 231(3):649-53. PubMed ID: 6502518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo modulation of alternative pathways of P-450-catalyzed cyclophosphamide metabolism: impact on pharmacokinetics and antitumor activity.
    Yu LJ; Drewes P; Gustafsson K; Brain EG; Hecht JE; Waxman DJ
    J Pharmacol Exp Ther; 1999 Mar; 288(3):928-37. PubMed ID: 10027828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereoselective metabolism of the enantiomers of hexobarbital.
    Furner RL; McCarthy JS; Stitzel RE; Anders MW
    J Pharmacol Exp Ther; 1969 Oct; 169(2):153-8. PubMed ID: 5824599
    [No Abstract]   [Full Text] [Related]  

  • 27. A comparative review of the pharmacokinetics of boric acid in rodents and humans.
    Murray FJ
    Biol Trace Elem Res; 1998; 66(1-3):331-41. PubMed ID: 10050928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of the rate of hepatic portal vein infusion on hexobarbital pharmacokinetics in the rat.
    Joeres RP; Vermeulen NP; Breimer DD
    Pharmacology; 1988; 36(3):210-6. PubMed ID: 3368506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetics of drug action in disease states. XXXVI: Effect of cyclosporine on the pharmacodynamics and pharmacokinetics of a barbiturate (heptabarbital) in rats.
    Hoffman A; Levy G
    J Pharm Sci; 1990 Jan; 79(1):19-22. PubMed ID: 1968970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic differences in phenytoin pharmacokinetics. In vivo clearance and in vitro metabolism among inbred strains of mice.
    Atlas SA; Zweier JL; Nebert DW
    Dev Pharmacol Ther; 1980; 1(5):281-304. PubMed ID: 7438974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Total body clearance of circulating benzo(a)pyrene in conscious rats: effect of pretreatment with 3-methylcholanthrene and the role of liver and lung.
    Wiersma DA; Roth RA
    J Pharmacol Exp Ther; 1983 Sep; 226(3):661-7. PubMed ID: 6310077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The metabolic fate of hexobarbital in the rat.
    Holcomb RR; Gerber N; Bush MT
    J Pharmacol Exp Ther; 1974 Jan; 188(1):15-26. PubMed ID: 4809266
    [No Abstract]   [Full Text] [Related]  

  • 33. The influence of cyclobarbital and diazepam on drug metabolism in vitro and their binding to cytochrome P-450.
    Wierzba W; Müller D; Richter K; Klinger W
    Biomed Biochim Acta; 1984; 43(12):1425-30. PubMed ID: 6152537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of model traumatic injury on hepatic drug metabolism in the rat. II. In vivo metabolism of hexobarbital and zoxazolamine.
    Griffeth LK; Rosen GM; Rauckman EJ
    Drug Metab Dispos; 1984; 12(5):582-7. PubMed ID: 6149908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of vephylline on hexobarbital metabolism after single and multiple administrations].
    Mincheva M; Chanade A
    Eksp Med Morfol; 1989; 28(1):19-22. PubMed ID: 2743925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of phenobarbital, 3-methylcholanthrene, and retinoid pretreatment on disposition of orally administered retinoids in mice.
    Kalin JR; Wells MJ; Hill DL
    Drug Metab Dispos; 1984; 12(1):63-7. PubMed ID: 6141914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender differences in the pharmacodynamics of barbiturates in rats.
    Hoffman A; Levy G
    Pharm Res; 1989 Nov; 6(11):976-81. PubMed ID: 2574444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hexobarbital blood levels and effects on EEG in the presence and absence of caffeine.
    Milon H; Atkinson J
    Arzneimittelforschung; 1979; 29(11):1724-7. PubMed ID: 120744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of phenobarbital on stereoselective metabolism of ifosfamide in rats.
    Lu H; Wang JJ; Chan KK; Young D
    Drug Metab Dispos; 1998 May; 26(5):476-82. PubMed ID: 9571229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heme enhances hexobarbital metabolism in perfused rat liver after drug-mediated destruction of cytochrome P-450.
    Farrell GC; Gollan JL; Correia MA; Schmid R
    J Pharmacol Exp Ther; 1981 Aug; 218(2):363-7. PubMed ID: 7252836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.